Its current product development programs include fostamatinib, an inhibitor for rheumatoid arthritis, R343, an inhibitor for asthma, R333 for the treatment of lupus of the skin and R348 for the treatment of keratoconjunctivitis sicca or chronic dry eye. (borntosell.com)
Ignored cases of keratoconjunctivitis sicca often make way for the appearance of blood cells on corneas, which can give them hazy and lifeless looks. (dogcare.dailypuppy.com)
Signs of eosinophilic keratoconjunctivitis include tearing, squinting, redness and cloudiness. (animaleyegroup.com)